Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$982,270.00
Oct 1, 2013
Post-transcriptional gene regulation during Drosophila development
$100,000.00
Jul 1, 2016
Gene-Environment Interactions in Acute Coronary Syndrome
$1,154,195.00
Apr 1, 2018
Identifying Autosomal Recessive Genes for Intellectual Disability
$514,263.00
Jul 1, 2015
Regulation of gene expression by protein sumoylation
$52,900.00
Oct 10, 2014
$822,107.00
Oct 1, 2011
Evaluation of a new cognitive therapy (inference-based therapy) for the treatment of obsessional compulsive disorder
$160,000.00
Apr 1, 2013
Anti-Biofilm Therapy
$75,000.00
Jul 1, 2024
For-profit organization
Analytics Development to Support Production of CAR-T Cell Therapy
1020634
Development of a qPCR method for CD19 CAR Gene Expression and Vector Copy Number (VCN)
3.
$750,000.00
Apr 1, 2021
Not-for-profit organization or charity
Automation of precision gene editing platform to accelerate engineering of human induced pluripotent stem cells
991892
Exploiting genome editing technology to engineer enhanced and novel therapeutic attributes into clinically relevant cell types represents a disruptive modality to circumvent current challenges in cell- and gene-based therapies. The goal of this Project is to establish genome engineering tools amenable to automated and high throughput platforms that facilitate the engineering of therapeutic attributes into human induced pluripotent stem cells (iPSCs). Once established, these tools will be foundational to accelerating the innovation and discovery cycles of engineered cell-based therapies with increased safety, affordability and accessibility in the space of regenerative medicine and immunotherapy.
$750,000.00
Apr 1, 2021
Not-for-profit organization or charity
Automation of precision gene editing platform to accelerate engineering of human induced pluripotent stem cells
991892
Exploiting genome editing technology to engineer enhanced and novel therapeutic attributes into clinically relevant cell types represents a disruptive modality to circumvent current challenges in cell- and gene-based therapies. The goal of this Project is to establish genome engineering tools amenable to automated and high throughput platforms that facilitate the engineering of therapeutic attributes into human induced pluripotent stem cells (iPSCs). Once established, these tools will be foundational to accelerating the innovation and discovery cycles of engineered cell-based therapies with increased safety, affordability and accessibility in the space of regenerative medicine and immunotherapy.